Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Pharmalot, Pharmalittle: Biogen’s Spinraza gets the green light from FDA

  • Meghana Keshavan

By Meghana Keshavan Dec. 27, 2016

Reprints
Alex Hogan/STAT

Happy mid-holiday, all! Hope your hearts are warm and your belt loops happily strained. ’Tis the season.

So this is Meghana of the Readout, filling in for Ed for today’s Pharmalittle. Of course, given the dearth of juicy news during year’s end, this iteration is maybe more “Pharmalittlest”:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Make a wish: The top 5 requests from children…
Make a wish: The top 5 requests from children and adults facing the end of life
Novartis data set up multibillion-dollar battle over breast cancer…
Novartis data set up multibillion-dollar battle over breast cancer drugs
A half century after Prozac, a new generation of…
A half century after Prozac, a new generation of depression drugs is bringing hope to a…
Ohio attorney general accuses pharmacy benefit managers of drug…
Ohio attorney general accuses pharmacy benefit managers of drug price fixing
Bernie Sanders’ accidentally great drug pricing idea
Bernie Sanders’ accidentally great drug pricing idea

Comments are closed.

Recommended Stories